High throughput (HTP) screening is a method used in drug discovery to rapidly test large numbers of compounds for their potential as therapeutic agents. This approach is significant because it allows a screening facility screening to analyze millions of compounds in a short period, increasing the chances of identifying promising small molecule drug candidates. Recently ultra-high throughput screening (UHTP) has improved the drug discovery process and enabled drug developers to increase their screening load. It is built on advancements in robotics and automation.

What is high throughput (HTP) screening?

HTP screening is a fully automated approach that enables the rapid execution of numerous biological or chemical screening assays each day. It relies on liquid handling devices, highly sensitive detectors, robotics, high content imagers, advanced data processing, and control software to achieve its high throughput capabilities. This process is largely a plate-based method that is run in 96, 384, or 1536 well plates.

Why is HTP screening important in drug discovery?

HTP screening can rapidly evaluate compounds, accelerating small molecule drug discovery, reducing costs, and enabling pharmacological candidate identification (agonists and antagonists) for clinical studies.

HTP Screening Techniques

Several methods are employed for HTP screening. These include

• Fluorescence-based HTS assays, which use fluorescent markers to detect specific interactions or enzyme activities.
• Luminescence-based cellular assays, which utilize light emission to quantify biological reactions.
• Label-free methods, such as surface plasmon resonance and mass spectrometry, which measure changes in physical or chemical properties.
• Microfluidics-based platforms, which enable parallel processing of samples in microliter or nanoliter volumes.
• Next-generation sequencing techniques, which allow simultaneous screening of vast numbers of genetic or molecular targets.

High Throughput Screening Applications in Drug Discovery and Development

Screening large compound libraries

HTS drug discovery enables rapid and efficient evaluation of extensive collections of bioactive compounds, typically at a rate of several thousand compounds per day or week.

Identification of drug targets

Academic, bioinformatics, and pharmacology researchers increasingly use HTP facilities to discover probes for chemical biology, screen active compounds, identify potential targets, expand target knowledge, and enhance therapeutic identification and insights.

Assessment of drug efficacy and safety

In the pharmaceutical industry, HTP screening enables the identification of potential drug candidates with desired biological responses, safety profiles and low toxicity.

Accelerating drug development processes

HTP screening is a powerful tool in drug discovery, rapidly screening a large number of compounds to accelerate candidate identification and streamline drug development.

Challenges and Limitations of HTP Screening

Data management and analysis

The processing and statistical analysis of data generated by HTP screening can be challenging. Large amounts of data are generated from the assays and require dedicated teams to analyze. This step can quickly become the bottleneck for HTP screening.

Cost considerations

Though HTP screening can be a cost-effective approach for reducing development timelines, the need for high-quality data and the complexity of the technology can sometimes increase costs. Required compound volumes, single-use plastics, reagents and labor are traditionally the largest contributors.

Technical limitations and false positives/negatives

Technical limitations can be challenging to address and may require post-processing of screening results. False positives can be caused by compound interference, while false negatives can be caused by the presence of reactive functional groups or the instability of compounds.

Ethical considerations

Ethical considerations in HTP screening include the use of animal models, the potential for misuse of screening results, and the need to ensure that the benefits of the technology outweigh any potential risks.

Future Directions and Innovations in HTP Screening

Advancements in high throughput screening technology and automation

Automated HTP screening has revolutionized drug discovery by rapidly screening massive compound libraries, with the capacity to test thousands of compounds daily through cutting-edge robotics and automation.

Integration of artificial intelligence and machine learning

Innovations in HTP screening impact synthetic biology and integrate AI and machine learning and computational methods, enabling intelligent analysis of extensive data. AI algorithms predict compound activity and toxicity, aiding candidate selection.

Miniaturization

Miniaturization can revolutionize drug discovery by enabling rapid, cost-effective screening of many compounds. Micro- or nanofluidics would reduce the compound or reagent volumes needed to run assays.

Potential impact on healthcare and research

HTP screening innovations impact healthcare and research by accelerating drug discovery. This can lead to improved treatment and new medicines.

recent-articles